INS and obesity disorder: Gene editing or specific inhibitors could be applied to our system to define the effects of adipokines such as adiponectin, leptin, resistin and omentin or metabolic and inflammatory pathways that impact hepatic insulin response in the setting of obesity and WAT inflammation2.